To generate tumor-specific T cells, mature DCs were cocultured with isolated CD8+ T cells at a 5:1 ratio in VIVO medium (Lonza, 04-418Q) supplemented with 25 IU/mL IL2 (PeproTech, 200-02-100) for 6 days. Here, CD8A is linked to neoplasm.